The 30 bpm threshold: what happens when you almost have POTS
The POTS diagnostic criterion of a 30 bpm heart rate rise on standing is a clinical convention, not a biological cliff edge. This piece examines what sub-threshold orthostatic tachycardia means in practice.
Postural orthostatic tachycardia syndrome (POTS) is diagnosed when heart rate increases by at least 30 beats per minute on standing (or head-up tilt), sustained for at least 10 minutes, without significant orthostatic hypotension, in the context of symptoms. In patients over 65 the criterion is 30 bpm; in patients aged 12–19 it’s 40 bpm.
The 30 bpm criterion is a clinical convention. It was arrived at through consensus and validated against population data — it’s the threshold that best discriminates between symptomatic patients and healthy controls. But it’s a threshold imposed on a continuous biological variable, and the evidence is clear that meaningful pathology exists below it.
Where the 30 bpm threshold came from
The criterion was established primarily through work by Schondorf, Low, and colleagues in the 1990s and formalised in the 1999 American Autonomic Society consensus statement. The 30 bpm figure was chosen because it captures most patients with symptomatic orthostatic intolerance while excluding most healthy controls during normal daily variation.
A healthy person standing up will have a heart rate rise of 10–20 bpm. A rise of 25–29 bpm in a symptomatic patient is not physiologically normal — it’s just below the diagnostic threshold. A rise of 31 bpm in an asymptomatic person technically meets criteria but may not warrant the same clinical response.
The threshold does what thresholds are supposed to do: create a clinically workable distinction for the purposes of diagnosis and treatment allocation. It does not reflect a biological boundary between sick and well.
What happens at 25–29 bpm
Research consistently shows that patients with orthostatic heart rate rises in the 25–29 bpm range (sometimes called “borderline” or “subthreshold” POTS) have:
- Similar symptom profiles to patients meeting full POTS criteria
- Similar quality of life impairment
- Similar pathophysiological mechanisms (reduced circulating volume, reduced venous return, sympathetic overdrive)
- Similar responses to standard POTS treatments
A 2021 study by Fedorowski et al. examined a large cohort of orthostatic tachycardia patients and found that the 30 bpm threshold was a poor predictor of symptom severity or treatment response. Patients with a 28 bpm rise and significant symptoms were more like POTS patients than like healthy controls on every clinical measure studied.
This isn’t a niche finding. Multiple groups have replicated the observation that the functional boundary between POTS and its sub-threshold equivalent is blurry to the point of clinical irrelevance in individual patients.
The clinical consequences
The consequences of not meeting the 30 bpm threshold, in practice, are significant:
Diagnostic exclusion — without a POTS diagnosis, access to specialist autonomic clinics is limited. Many referral criteria specify “confirmed POTS” or use the 30 bpm criterion as a gate. Borderline patients may be discharged from cardiology after a normal tilt test with no follow-up plan.
Treatment access — medications that have evidence for POTS (ivabradine, pyridostigmine, beta blockers at appropriate doses, fludrocortisone) are prescribed on the basis of diagnosis. Without a POTS label, getting these medications can be significantly harder, even when the clinical picture is essentially identical.
Legitimacy — the diagnostic label carries weight in terms of how patients are treated by healthcare providers, employers, and disability systems. “I have something that looks like POTS but doesn’t quite meet criteria” is harder to communicate than “I have POTS.”
Why measurement variability matters here
Heart rate during a standing test is not a stable measurement. It varies with:
- Time of day (circadian HR variation)
- Hydration status (dehydration worsens orthostatic tachycardia)
- Menstrual cycle phase (significant variation in women with POTS and related conditions)
- Recent activity
- Ambient temperature
- Anxiety about the test itself
- Duration of time spent standing before the rise is measured
A patient who has a 28 bpm rise at clinic after good hydration on a cool morning might have a 34 bpm rise at home on a warm afternoon after a bad night. The threshold-based diagnosis depends heavily on the conditions of the single measurement.
Wearable tracking data — heart rate changes on standing captured across multiple days and conditions — can demonstrate consistent orthostatic tachycardia even when a single clinic measurement falls below threshold. Some specialists will weight longitudinal home data alongside clinic measurements.
HRV as a supplementary criterion
Heart rate variability data provides additional information about autonomic function that isn’t captured in the resting-to-standing HR change. Persistently low RMSSD (reflecting reduced parasympathetic tone) and elevated resting heart rate, captured over weeks by a wearable device, can corroborate a clinical picture of autonomic dysfunction even when the standing HR rise doesn’t quite reach 30 bpm.
HRV isn’t a diagnostic criterion for POTS, but it can help clinicians see a pattern of autonomic dysfunction in the longitudinal data that the snapshot tilt measurement may underestimate.
The alternative diagnoses
If the POTS threshold isn’t met but symptoms are consistent with orthostatic intolerance, what else can be said?
Orthostatic intolerance (OI) is a broader term that covers any symptomatic intolerance of upright posture, regardless of whether a specific heart rate threshold is met. It’s acknowledged in specialist literature and can be a reasonable primary diagnosis when the threshold isn’t met.
Dysautonomia — a broader term for autonomic nervous system dysfunction — can also be applied when the physiological picture supports it even without meeting POTS criteria.
Inappropriate sinus tachycardia (IST) overlaps with POTS in some presentations, particularly where elevated resting heart rate is the dominant feature alongside orthostatic intolerance.
None of these labels has the same clinical weight as POTS, but they’re more accurate than “nothing wrong” when the symptoms are real and the physiological findings point in a consistent direction.
What to do if you’re sub-threshold
If your standing heart rate rise consistently falls in the 20–29 bpm range with typical POTS symptoms, the most useful approaches are:
Request a formal tilt table test if you’ve only had an active stand test. Passive head-up tilt, held for 10 minutes, may reveal a larger or more sustained HR rise than an active stand.
Try standard first-line POTS management — increased salt and fluid, compression garments, head-of-bed elevation — regardless of diagnostic label. These are safe, evidence-based, and shouldn’t require a specific diagnosis.
Document with home monitoring. Wearable devices that track heart rate throughout the day can build a longitudinal picture. A resting heart rate consistently above 90 bpm and clear HR elevation on movement, documented over weeks, is useful clinical information.
Request specialist review framed around orthostatic intolerance and post-viral dysautonomia rather than POTS specifically. A cardiologist or autonomic specialist who understands the spectrum of disease will be more useful than one applying strict diagnostic criteria as a gate.
The bottom line
30 bpm is a useful clinical convention that does a reasonable job of identifying most people with significant orthostatic tachycardia. It is not a physiological truth. A person with a 27 bpm rise, daily symptoms of orthostatic intolerance, and abnormal HRV has autonomic dysfunction that deserves clinical attention regardless of whether the threshold is met.
The diagnostic system creates real barriers for people who fall just below it, and those barriers are not clinically justified by the evidence. Understanding this is useful for anyone navigating the healthcare system with sub-threshold findings.
References
Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology. 1993;43(1):132–137.
Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69–72.
Fedorowski A, Burrows D, Hamrefors V, et al. Orthostatic intolerance: multiple diseases with the same symptoms but different underlying mechanisms. Ann Med. 2021;53(1):2110–2122.
Raj SR. Postural tachycardia syndrome (POTS). Circulation. 2013;127(23):2336–2342.